pharma · Advanced Solid Tumors · Non-Hodgkin's Lymphoma
Liposome Company
Taiwan Liposome Company
Liposome Company patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
CN HQ
21 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 21
- Programs
- 6
- Drugs
- 7
- Patents
- 0
Liposome Company patents
0 pharmaceutical patents indexed for Liposome Company. 0 expire within 24 months.
Liposome Company has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Liposome Company have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Liposome Company patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.